← Back to Browse
ProductDiagnostic Tests

Organoid Individualized Drug Sensitivity Detection with Next-Generation Sequencing (Beixin Kang)

China

A comprehensive clinical diagnostic service combining organoid-based drug sensitivity testing with next-generation sequencing analysis. This integrated approach provides personalized cancer treatment recommendations by identifying both drug responses and genomic profiles to optimize therapeutic outc...

Manufactured by

China

Accurate International Biotechnology is an innovative biotech company with organoid technology as its core focus, serving personalized medicine, drug development, and regenerative medicine. As the Guangdong Provincial Organoid Engineering Technology Research Center, the company is ISO13485 certified with headquarters in Guangzhou and R&D centers in Beijing, Shanghai, Macau, and Milan. The company operates a comprehensive organoid technology platform covering reagents, biomaterials, automated equipment, chips, and AI databases.

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

50
Relevant manufacturers
matched to this product
79
Relevant products analyzed
for supplier coverage
20
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

12 of 79 closest product alternatives

79 products

Tumor Drug Sensitivity Analysis Service

Jiangsu Avatarget Biotechnology Limited Liability Company · China

Clinical service for personalized cancer drug response evaluation using patient-derived tumor organoids and organ chips. Supports precision medicine treatment selection and optimization.

View Details

Portable Occult Blood Test Kit

Suzhou Linaxin Biotechnology Co., Ltd. · China

A portable diagnostic test kit for detecting occult blood, designed for early cancer screening in digestive tract-related conditions. The product received Class II medical device registration certification from Shandong Province Drug Supervision and Management Bureau. It is manufactured by Lixin Nuo Kang, a wholly-owned subsidiary of Linaxin Biotechnology, and represents the company's technological capabilities in in vitro diagnostics for home-based early cancer screening.

View Details

HDS Tumor Drug Sensitivity Detection Service

PreceDo Pharmaceuticals Co.Ltd. · China

A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.

View Details

Drug Sensitivity Testing for Oncology

Shanghai Biotecan pharmaceuticals Co.,Ltd · China

Precision medicine test identifying optimal chemotherapy agents for individual tumors based on molecular characteristics. Guides targeted drug selection and improves treatment efficacy.

View Details

Cancer Diagnosis and Sequencing Solution

GENETRON HEALTH (BEIJING) CO., LTD · China

Comprehensive genomic sequencing platform for cancer diagnosis and characterization. Utilizes next-generation sequencing technology to identify genetic mutations and alterations in tumor samples. Supports treatment selection and clinical decision-making for oncology patients.

View Details

ONCOseeker™

GeneCker Co., Ltd. · South Korea

A cancer diagnosis platform product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for standardization of liquid biopsy diagnosis. Integrates sample collection, DNA sequencing via NGS or Sanger sequencing methods, and provides results in result booklet or PDF format.

View Details

Precision Medicine Diagnostic Platform

HealthTec Logix · Kuwait

Integrated diagnostic platform combining genomic sequencing with molecular analysis for precision medicine applications. Enables personalized treatment planning and early disease detection.

View Details

Cancer Drug Resistance Platform

HEMEX AG · Switzerland

Comprehensive cancer drug resistance diagnostic platform providing insights into treatment resistance mechanisms. Guides clinical decision-making for resistant cancer cases.

View Details

Genomic Diagnostic Solutions

HealthTec Logix · Kuwait

Comprehensive genomic diagnostic platform providing precision analysis for disease detection and personalized treatment planning. Integrates molecular-based technologies with clinical interpretation for accurate patient stratification.

View Details

Oncology Genetic Testing Solutions

APPOLON BIOTECK SAS · France

In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.

View Details

NGS-Based Cancer Panel

Burning Rock Dx Co. Ltd. · China

Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.

View Details

Cancer Genomic Testing Kit

Wuhan YZY Medical Science and Technology Co.,Ltd. · China

Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.

View Details

67 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products